Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
524.00    0.00 (0.00%)
Bid:
520.00
Ask:
528.00
Spread: 8.00 (1.538%)
Market Cap: £867.04m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Trading Update

26 Jul 2018 07:00

RNS Number : 7894V
Oakley Capital Investments Limited
26 July 2018
 

 

26 July 2018

Oakley Capital Investments Limited

 

Trading update for the six months ended 30 June 2018

 

Oakley Capital Investments Limited1 (AIM: OCI, the "Company") which provides its shareholders with access to a portfolio of high quality companies through its investments in the Oakley Funds2, today announces a trading update for the six months ended 30 June 2018.

NAV Range

The Company's net asset value is estimated to be in the range of £524m - £530m, which represents a NAV per share of £2.56 - £2.59, compared with £2.45 per share reported at 31 December 2017.

 

Performance

There have been positive revaluations in the underlying portfolio across Oakley's three core sectors: digital consumer, TMT and education. Uplifts have been driven by the portfolio companies' continued ability to exhibit strong performance and growth in profitability. The uplift in NAV was offset by 12 pence due to a fall in the share price of Time Out Group Plc during the period. Time Out continues to make progress and its Board remain confident of meeting their strategic and financial goals.

 

Realisations

During the period OCI has benefitted from the realisations of Parship Elite, Verivox and Facile, which generated a combined gross money multiple of 3.9x and returned £102.3 million to OCI. These exits reflect Oakley's continued success in the digital consumer space as well as its ability to create value and identify long term attractive assets. The realisations were at a combined 39% premium to the OCI's year-end look through value and increased the Company's NAV by 14 pence.

 

Investments

In the six months to 30 June 2018, OCI invested £62.1 million via the Oakley Funds, primarily relating to the acquisition of Career Partner Group and the reinvestment in Facile, as well as a follow-on investment in North Sails.

 

 

This announcement contains inside information.

- ends -

For further information please contact:

 

Oakley Capital Investments Limited+44 20 7766 6900Steven Tredget, Investor Relations

Greenbrook Communications Ltd+44 20 7952 2000Alex Jones / Matthew Goodman / Gina Bell

Liberum Capital Limited (Nominated Adviser & Broker)+44 20 3100 2000Gillian Martin / Jill Li

 

1 About Oakley Capital Investments Limited ("OCI")

Oakley Capital Investments Limited is a Bermudian company listed on AIM. OCI seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P., Oakley Capital Private Equity II, Oakley Capital Private Equity III and through co-investment opportunities.

 

LEI Number: 213800KW6MZUK12CQ815

 

2 About Oakley Capital Private Equity L.P. ("Fund I"), Oakley Capital Private Equity II ("Fund II") and Oakley Capital Private Equity III ("Fund III")

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II and Oakley Capital Private Equity III, are unlisted mid-market private equity funds with the aim of providing investors with significant long term capital appreciation. The investment strategy of the funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSELFMIFASEDW
Date   Source Headline
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTotal Voting Rights
25th Mar 20253:16 pmRNSTransaction in Own Shares
24th Mar 20257:00 amRNSCapital Allocation Update
13th Mar 20257:00 amRNSFinal Results for the Year Ended 31 December 2024
26th Feb 20257:00 amRNSNotice of Results and Investor Presentation
5th Feb 20257:00 amRNSDirector Dealing
5th Feb 20257:00 amRNSDirector Dealing
3rd Feb 20257:00 amRNSDirector Dealing
29th Jan 20257:00 amRNSTrading update for the year ended 31 December 2024
20th Dec 202410:49 amRNSDirector Dealing
20th Dec 202410:48 amRNSDirector Dealing
19th Dec 20247:00 amRNSNorth Sails: Conversion of Equity
13th Dec 20247:00 amRNSDirector Dealing
13th Dec 20247:00 amRNSDirector Dealing
20th Nov 20247:00 amRNSOakley Capital invests in Konzept & Marketing
11th Nov 20247:00 amRNSHolding(s) in Company
8th Nov 20244:52 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSAppointment of Non-Executive Director
24th Oct 20247:00 amRNSOakley Capital agrees sale of Schülerhilfe to LLCP
23rd Oct 20247:00 amRNSTrading update for the 3 months ended 30 Sep 2024
21st Oct 20247:00 amRNSHolding(s) in Company
7th Oct 20247:00 amRNSOakley Capital invests in Assured Data Protection
12th Sep 20247:00 amRNSInterim Results for the 6 months ended 30 June 24
2nd Sep 20247:00 amRNSOakley agrees sale of Ocean to Lloyds Register
29th Aug 20247:00 amRNSNotice of Results and Investor Presentation
13th Aug 20247:00 amRNSDirector Dealing
26th Jul 20247:00 amRNSDirector Dealing
24th Jul 20247:00 amRNSTrading Update for the 6 Months ended 30 June 2024
17th Jul 20243:52 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSOakley agrees sale of its investment in idealista
11th Jun 20247:00 amRNSOakley to invest in cybersecurity firm I-TRACING
7th Jun 20247:00 amRNSDirector Dealing
3rd Jun 20243:43 pmRNSResult of AGM
28th May 20247:00 amRNSOakley Capital invests in ProductLife Group
14th May 20247:00 amRNSOakley Capital invests in vitroconnect
8th May 20247:00 amRNSNotice of Annual General Meeting
24th Apr 20247:00 amRNSTrading Update for the 3 months ended 31 March 24
2nd Apr 20244:17 pmRNSUpdate from QuotedData
27th Mar 20247:00 amRNSDirector Dealing
27th Mar 20247:00 amRNSDirector Dealing
26th Mar 20245:46 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.